Home About us Manufacturing Products Alliances Careers Contact us

 

Production Capacity:

  •  A WHO-GMP aproved dedicated facility for manufacturing of anticancer products [tablets, capsules and injections (liquids and lyophylised] and anticancer API’s.
  • A WHO-GMP dedicated plant for hormonal products / biological products
  • A WHO-GMP dedicated cephalosporin plant with a seprate beta lactum facility.

General Formulations:

Form

Volume Capacity (in Lacs)

 

Per Day

Per Annum

Tablets: b Lactum & Non b Lactum

400

120000

Capsules: b Lactum & Non b Lactum

80

24000

Dry Syrups: Cephalosporins & Ampicillins

3

900

Liquid Orals: Syrups & Suspensions

1.5

450

Injectables: Dry Powders

4

1200

Injectables: Liquids - Amps and vials

7

2100

Form Fill & Seal (FFS)  Eye/Ear Drops

2

600

FFS  Phamraceutical Ijections & Water For Inj.

0.4

120

Soft Gelatin Caspules

 

 

Vitamins & other preparations

20

6000

 

Oncological Formulation Capacity:

Form

VolumeCapacity    / day

Capacity / month.

 

 

 

 

Tablets 

Uncoated 

1,50,000

35,00,000

Capsules 

Hard gelatin 

100,000 

2,600,000 

Ampoules 

Up to 10 ml 

40000

8,00,000 

Vials ( Liquid ) 

Up to 50 ml 

30000

6,00,000 

Vials ( Lyophilised ) 

Up to 50 ml 

14,000 per cycle

1,82,0000 

Vials ( Powder ) 

Up to 30 ml

15,000

3,75,000

 

 

 

 

Oncology API
Bulk Drug Manufacturing Facility.

  • Dedicated Sterile area for making sterile bulk drugs.
  • Separate area for manufacturing oncology API’s as per schedule M
  •  Upto 300 lit SS reactor assembly.
  • Upto 150 GLR 2 Nos.
  • 100 Lit Glass reactor 4 No’s.
  • 50 Lit Glass reactor 1 Nos.  

 

 
   Copyrights © reserved for Zuviuslifesciences.in Site Designed & Maintained By: Kismat. N. Raval